# US 8,278,107 B2 · Compositions and methods for regulating RNA translation via CD154 CA-dinucleotide repeat

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,107 B2
- Document ID: US8278107B2
- Status: Granted
- Kind: B2
- Application number: 12/699,180
- Filed: 2010-02-03
- Published: 2010-06-03
- Granted: 2012-10-02
- Earliest claimed: 2005-09-13
- Assignees: Trustees of Dartmouth College
- Inventors: William F. C. Rigby
- Web page: https://patentgrep.com/patent/US8278107B2

## CPC

- C12N 15/67: General methods for enhancing the expression
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Compositions and methods for regulating CD154 gene expression are provided that rely on the interaction of hnRNP L with the CA-dinucleotide rich sequence of the 3′-untranslated region of CD154.

## Claims

### Claim 1

A method for inhibiting the nuclear export or translation of a ribonucleic acid comprising: contacting an isolated cell or tissue containing a CA-dinucleotide rich sequence of the CD154 mRNA 3′-untranslated region operatively-linked to a heterologous ribonucleic acid with an agent which binds to the CA-dinucleotide rich sequence, wherein said agent is selected from the group consisting of a purified hnRNP L protein, and a recombinant expression vector expressing hnRNP L protein, and a recombinant expression vector expressing an siRNA which binds the CA-dinucleotide rich sequence or hnRNP L, so that the nuclear export or translation of the ribonucleic acid is inhibited.
